Inventor · disambiguated record
Logan A. Baker
Also filed as: BAKER LOGAN A
5 granted patents·8 pending applications·16 citations·filing 2018–2025
75Inventor score
Files withUNIV VANDERBILT13
Top patents by PatentIndex Score
13 records- 0195US11820757B2Antagonists of the muscarinic acetylcholine receptor M4UNIV VANDERBILT·Filed 2022·Granted Nov 21, 2023·5 cites·20 claims
- 0293US11884676B2Substituted pyrimido[1,2-b]pyridazines as positive allosteric modulators of the muscarinic acetylcholine receptor M4UNIV VANDERBILT·Filed 2023·Granted Jan 30, 2024·4 cites·30 claims
- 0390US11299481B2Antagonists of the muscarinic acetylcholine receptor M4UNIV VANDERBILT·Filed 2018·Granted Apr 12, 2022·5 cites·20 claims
- 0481US11325896B2Antagonists of the muscarinic acetylcholine receptor M4UNIV VANDERBILT·Filed 2018·Granted May 10, 2022·2 cites·20 claims
- 0571US2025263417A1Substituted pyrimido[1,2-b]pyridazines as positive allosteric modulators of the muscarinic acetylcholine receptor m4UNIV VANDERBILT·Filed 2025·Application pending·0 cites
- 0667US12331055B2Substituted pyrimido[1,2-b]pyridazines as positive allosteric modulators of the muscarinic acetylcholine receptor M4UNIV VANDERBILT·Filed 2021·Granted Jun 17, 2025·0 cites·45 claims
- 0759US2025026752A1Positive allosteric modulators of the muscarinic acetylcholine receptor m4UNIV VANDERBILT·Filed 2022·Application pending·0 cites
- 0859US2025002507A17,8-dihydro-5h-1,6-naphthyridine derivatives as positive allosteric modulators of the muscarinic acetylcholine receptor m4 for treating neurological and psychiatric disordersUNIV VANDERBILT·Filed 2022·Application pending·0 cites
- 0959US2025101041A1Positive allosteric modulators of the muscarinic acetylcholine receptor m4UNIV VANDERBILT·Filed 2023·Application pending·0 cites
- 1059US2025230155A17,8-dihydro-5h-1,6-naphthyridine derivatives as positive allosteric modulators of the muscarinic acetylcholine receptor m4 for treating neurological and psychiatric disordersUNIV VANDERBILT·Filed 2022·Application pending·0 cites
- 1159US2025017935A17,8-dihydro-5h-1,6-naphthyridine derivatives as positive allosteric modulators of the muscarinic acetylcholine receptor m4 for treating neurological and psychiatric disordersUNIV VANDERBILT·Filed 2022·Application pending·0 cites
- 1254US2024228468A1N-(6-((octahydrocyclopenta[c]pyrrol-5-yi)amino)pyridazin-3-yl)phenyl)carboxamide and (6- ((octahydrocyclopenta[c]pyrrol-5-yl)amino)pyridazin-3-yl)benzamide derivatives as machr m4 antagonists for the treatment of neurodegenerative disordersUNIV VANDERBILT·Filed 2022·Application pending·0 cites
- 1347US2023150986A1Antagonists of the muscarinic acetylcholine receptor m4UNIV VANDERBILT·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Logan A. Baker files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →